WO2026017129 - HEXAHYDROPYRIDINE COMPOUND AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/017129
Publication Date
22.01.2026
International Application No.
PCT/CN2025/109193
International Filing Date
17.07.2025
Title **
[English]
HEXAHYDROPYRIDINE COMPOUND AND USE THEREOF
[French]
COMPOSÉ HEXAHYDROPYRIDINE ET SON UTILISATION
[Chinese]
一种六氢吡啶类化合物及其用途
Applicants **
CHENGDU SHIBEIKANG BIOMEDICAL TECHNOLOGY CO., LTD.
Inventors
ZENG, Yanqun
ZHOU, Guanglin
ZHU, Xucheng
HUANG, Long
FU, Haixia
MOU, Xia
TAN, Shaojun
Priority Data
202410958333.9
17.07.2024
CN
202411048580.1
01.08.2024
CN
202510043203.7
10.01.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1815 | |
| EPO | Filing, Examination, Granting | 12116 | |
| Japan | Filing, Examination, Granting | 2018 | |
| South Korea | Filing, Examination, Granting | 1853 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,542
Contact Us
Abstract[English]
Disclosed in the present invention are a hexahydropyridine compound and a use thereof. Specifically, the present invention relates to compounds of formula I and formula II, or isomers and pharmaceutically acceptable salts thereof, which show high activity in inhibiting platelet aggregation, and can be used for preventing or treating thrombus, embolism and/or cardiovascular diseases.[French]
La présente invention concerne un composé hexahydropyridine et son utilisation. Plus particulièrement, la présente invention concerne des composés de formule I et de formule II, ou des isomères et des sels pharmaceutiquement acceptables de ceux-ci, qui présentent une activité élevée dans l'inhibition de l'agrégation plaquettaire, et peuvent être utilisés pour prévenir ou traiter un thrombus, une embolie et/ou des maladies cardiovasculaires.[Chinese]
本发明公开了一种六氢吡啶类化合物及其用途。具体地，本发明涉及一种如式I和式II的化合物或其异构体、药学上可接受的盐，在抑制血小板凝集方面显示较高活性，可用于预防或治疗血栓、栓塞和/或心血管疾病。